What a joke. 1st, ONCS isn't even pursuing a vaccine so I am not sure how they can even be listed. Second, IL-12 as a stand alone treatment is dead. Why should they win an award for something they aren't even pursuing? The standard of care has surpassed ONCS's current clinical development and their only hope is the Keytruda combination trial. Unfortunately the CEO will not disclose the nature of the delays and instead, relies on his twitter account to keep shareholders uninformed.
I guess this is what you get when the CEO is 34 year old, Poly Sci major put in place by his uncle.